These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 16785534

  • 1. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
    Asokan R, Hua J, Young KA, Gould HJ, Hannan JP, Kraus DM, Szakonyi G, Grundy GJ, Chen XS, Crow MK, Holers VM.
    J Immunol; 2006 Jul 01; 177(1):383-94. PubMed ID: 16785534
    [Abstract] [Full Text] [Related]

  • 2. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220.
    Sarrias MR, Franchini S, Canziani G, Argyropoulos E, Moore WT, Sahu A, Lambris JD.
    J Immunol; 2001 Aug 01; 167(3):1490-9. PubMed ID: 11466369
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).
    Young KA, Chen XS, Holers VM, Hannan JP.
    J Biol Chem; 2007 Dec 14; 282(50):36614-25. PubMed ID: 17925391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules.
    Molina H, Perkins SJ, Guthridge J, Gorka J, Kinoshita T, Holers VM.
    J Immunol; 1995 May 15; 154(10):5426-35. PubMed ID: 7730644
    [Abstract] [Full Text] [Related]

  • 11. The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells.
    Henchoz-Lecoanet S, Jeannin P, Aubry JP, Graber P, Bradshaw CG, Pochon S, Bonnefoy JY.
    Immunology; 1996 May 15; 88(1):35-9. PubMed ID: 8707347
    [Abstract] [Full Text] [Related]

  • 12. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W.
    EMBO J; 1991 Apr 15; 10(4):919-26. PubMed ID: 1849076
    [Abstract] [Full Text] [Related]

  • 13. Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.
    Kulik L, Laskowski J, Renner B, Woolaver R, Zhang L, Lyubchenko T, You Z, Thurman JM, Holers VM.
    J Immunol; 2019 Dec 15; 203(12):3136-3147. PubMed ID: 31732528
    [Abstract] [Full Text] [Related]

  • 14. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
    Hannan JP, Young KA, Guthridge JM, Asokan R, Szakonyi G, Chen XS, Holers VM.
    J Mol Biol; 2005 Feb 25; 346(3):845-58. PubMed ID: 15713467
    [Abstract] [Full Text] [Related]

  • 15. Structure of complement receptor 2 in complex with its C3d ligand.
    Szakonyi G, Guthridge JM, Li D, Young K, Holers VM, Chen XS.
    Science; 2001 Jun 01; 292(5522):1725-8. PubMed ID: 11387479
    [Abstract] [Full Text] [Related]

  • 16. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).
    Clemenza L, Isenman DE.
    J Immunol; 2000 Oct 01; 165(7):3839-48. PubMed ID: 11034390
    [Abstract] [Full Text] [Related]

  • 17. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).
    Asokan R, Banda NK, Szakonyi G, Chen XS, Holers VM.
    Mol Immunol; 2013 Jan 01; 53(1-2):99-110. PubMed ID: 22885687
    [Abstract] [Full Text] [Related]

  • 18. Structure of complement receptor (CR) 2 and CR2-C3d complexes.
    Hannan J, Young K, Szakonyi G, Overduin MJ, Perkins SJ, Chen X, Holers VM.
    Biochem Soc Trans; 2002 Nov 01; 30(Pt 6):983-9. PubMed ID: 12440958
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.
    Young KA, Herbert AP, Barlow PN, Holers VM, Hannan JP.
    J Virol; 2008 Nov 01; 82(22):11217-27. PubMed ID: 18786993
    [Abstract] [Full Text] [Related]

  • 20. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21.
    Aubry JP, Pochon S, Gauchat JF, Nueda-Marin A, Holers VM, Graber P, Siegfried C, Bonnefoy JY.
    J Immunol; 1994 Jun 15; 152(12):5806-13. PubMed ID: 7515913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.